Xynomic Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Xynomic Pharma and buy or sell other stocks, ETFs, and their options commission-free!About XYNO
Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles.
CEOYinglin Mark Xu, MBA
CEOYinglin Mark Xu, MBA
Employees—
Employees—
HeadquartersShanghai, Shanghai
HeadquartersShanghai, Shanghai
Founded2016
Founded2016
Employees—
Employees—
XYNO Key Statistics
Market cap102.73M
Market cap102.73M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.84
52 Week high$3.84
52 Week low$0.2001
52 Week low$0.2001
Stock Snapshot
Xynomic Pharma(XYNO) stock is priced at $2.22, giving the company a market capitalization of 102.73M.
On 2026-03-10, Xynomic Pharma(XYNO) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0.
The stock's 52-week range extends from a low of $0.20 to a high of $3.84.
The stock's 52-week range extends from a low of $0.20 to a high of $3.84.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.